SYN Annual CFF
$74.00 M
+$70.64 M+2103.10%
31 December 2021
Summary:
As of February 5, 2025, SYN annual cash flow from financing activities is $74.00 million, with the most recent change of +$70.64 million (+2103.10%) on December 31, 2021. During the last 3 years, it has risen by +$44.91 million (+154.41%).SYN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Quarterly CFF
$0.00
+$1.38 M+100.00%
30 June 2022
Summary:
As of February 5, 2025, SYN quarterly cash flow from financing activities is $0.00, with the most recent change of +$1.38 million (+100.00%) on June 30, 2022. Over the past year, it has stayed the same.SYN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN TTM CFF
-$1.38 M
$0.000.00%
30 June 2022
Summary:
As of February 5, 2025, SYN TTM cash flow from financing activities is -$1.38 million, unchanged on June 30, 2022. Over the past year, it has dropped by -$78.74 million (-101.78%).SYN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYN Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2103.1% | 0.0% | -101.8% |
| 3 y3 years | +154.4% | 0.0% | -100.0% |
| 5 y5 years | +300.5% | -100.0% | -100.0% |
SYN Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -100.0% | -101.8% |
Synthetic Biologics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $0.00(-100.0%) | -$1.38 M(0.0%) |
| Mar 2022 | - | -$1.38 M(<-9900.0%) | -$1.38 M(-101.9%) |
| Dec 2021 | $74.00 M(+2103.1%) | $0.00(0.0%) | $74.00 M(-4.3%) |
| Sept 2021 | - | $0.00(0.0%) | $77.36 M(0.0%) |
| June 2021 | - | $0.00(-100.0%) | $77.36 M(0.0%) |
| Mar 2021 | - | $74.00 M(+2103.1%) | $77.36 M(+2203.1%) |
| Dec 2020 | $3.36 M(>+9900.0%) | $3.36 M(>+9900.0%) | $3.36 M(>+9900.0%) |
| Sept 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2019 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2019 | - | $0.00(0.0%) | $22.67 M(-21.0%) |
| June 2019 | - | $0.00(0.0%) | $28.69 M(-1.4%) |
| Mar 2019 | - | $0.00(-100.0%) | $29.09 M(0.0%) |
| Dec 2018 | $29.09 M(+57.4%) | $22.67 M(+276.4%) | $29.09 M(+352.9%) |
| Sept 2018 | - | $6.02 M(+1405.5%) | $6.42 M(-49.8%) |
| June 2018 | - | $400.00 K(>+9900.0%) | $12.80 M(-29.1%) |
| Mar 2018 | - | $0.00(-100.0%) | $18.04 M(-2.4%) |
| Dec 2017 | $18.48 M(-30.8%) | $1000.00(-100.0%) | $18.48 M(-57.8%) |
| Sept 2017 | - | $12.40 M(+119.6%) | $43.74 M(+36.8%) |
| June 2017 | - | $5.64 M(+1197.7%) | $31.98 M(+17.8%) |
| Mar 2017 | - | $435.00 K(-98.3%) | $27.14 M(+1.6%) |
| Dec 2016 | $26.71 M(-37.4%) | $25.26 M(+3865.5%) | $26.71 M(+1713.1%) |
| Sept 2016 | - | $637.00 K(-21.4%) | $1.47 M(-96.6%) |
| June 2016 | - | $810.00 K(>+9900.0%) | $43.49 M(+1.9%) |
| Mar 2016 | - | $0.00(-100.0%) | $42.68 M(0.0%) |
| Dec 2015 | $42.68 M(+124.3%) | $26.00 K(-99.9%) | $42.68 M(-30.8%) |
| Sept 2015 | - | $42.66 M(>+9900.0%) | $61.68 M(+224.2%) |
| June 2015 | - | $1000.00(-100.0%) | $19.02 M(-0.0%) |
| Dec 2014 | $19.03 M(+53.1%) | $19.02 M(>+9900.0%) | $19.03 M(+56.0%) |
| Sept 2014 | - | $0.00(0.0%) | $12.20 M(0.0%) |
| June 2014 | - | $0.00(-100.0%) | $12.20 M(0.0%) |
| Mar 2014 | - | $4000.00(-100.0%) | $12.20 M(-1.8%) |
| Dec 2013 | $12.43 M(+1.8%) | $12.20 M(>+9900.0%) | $12.43 M(+19.7%) |
| Sept 2013 | - | $0.00(0.0%) | $10.38 M(-0.9%) |
| June 2013 | - | $0.00(-100.0%) | $10.48 M(-3.8%) |
| Mar 2013 | - | $231.00 K(-97.7%) | $10.89 M(-10.7%) |
| Dec 2012 | $12.20 M(+74.8%) | $10.15 M(>+9900.0%) | $12.20 M(+492.6%) |
| Sept 2012 | - | $94.00 K(-77.4%) | $2.06 M(+4.8%) |
| June 2012 | - | $416.00 K(-73.0%) | $1.97 M(-59.1%) |
| Mar 2012 | - | $1.54 M(>+9900.0%) | $4.81 M(-31.1%) |
| Dec 2011 | $6.98 M(+588.3%) | $10.00 K(>+9900.0%) | $6.98 M(-0.1%) |
| Sept 2011 | - | $0.00(-100.0%) | $6.99 M(-11.6%) |
| June 2011 | - | $3.26 M(-12.3%) | $7.90 M(+69.3%) |
| Mar 2011 | - | $3.71 M(>+9900.0%) | $4.67 M(+360.2%) |
| Dec 2010 | $1.01 M(-2115.9%) | $18.30 K(-98.0%) | $1.01 M(+8.4%) |
| Sept 2010 | - | $915.10 K(+4237.0%) | $935.60 K(+2987.8%) |
| June 2010 | - | $21.10 K(-64.5%) | $30.30 K(+229.3%) |
| Mar 2010 | - | $59.50 K(-199.0%) | $9200.00(-118.3%) |
| Dec 2009 | -$50.30 K | -$60.10 K(-713.3%) | -$50.30 K(-613.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | $9800.00(>+9900.0%) | $9800.00(+880.0%) |
| June 2009 | - | $0.00(0.0%) | $1000.00(-50.0%) |
| Mar 2009 | - | $0.00(0.0%) | $2000.00(-100.2%) |
| Dec 2008 | -$895.60 K(-111.4%) | $0.00(-100.0%) | -$895.60 K(-115.7%) |
| Sept 2008 | - | $1000.00(0.0%) | $5.69 M(-11.1%) |
| June 2008 | - | $1000.00(-100.1%) | $6.40 M(+0.5%) |
| Mar 2008 | - | -$897.60 K(-113.6%) | $6.38 M(-19.0%) |
| Dec 2007 | $7.87 M(-44.2%) | $6.59 M(+827.1%) | $7.87 M(-45.0%) |
| Sept 2007 | - | $710.80 K(-2638.6%) | $14.31 M(+1.5%) |
| June 2007 | - | -$28.00 K(-104.7%) | $14.10 M(-2.3%) |
| Mar 2007 | - | $600.00 K(-95.4%) | $14.43 M(+2.3%) |
| Dec 2006 | $14.11 M(+531.4%) | $13.03 M(+2506.2%) | $14.11 M(+1206.2%) |
| Sept 2006 | - | $500.00 K(+66.7%) | $1.08 M(+86.2%) |
| June 2006 | - | $300.00 K(+7.0%) | $580.30 K(+107.0%) |
| Mar 2006 | - | $280.30 K(-14.9%) | $280.30 K(-92.6%) |
| Dec 2005 | $2.23 M(-59.2%) | - | - |
| Mar 2003 | - | $329.20 K(-33.9%) | $3.79 M(-30.8%) |
| Dec 2002 | $5.47 M(-6.2%) | $497.70 K(+5.3%) | $5.47 M(-14.8%) |
| Sept 2002 | - | $472.80 K(-81.0%) | $6.42 M(-28.6%) |
| June 2002 | - | $2.49 M(+23.5%) | $9.00 M(-178.9%) |
| Mar 2002 | - | $2.02 M(+39.3%) | -$11.41 M(-295.5%) |
| Dec 2001 | $5.84 M(+30.2%) | $1.45 M(-52.5%) | $5.84 M(-11.6%) |
| Sept 2001 | - | $3.05 M(-117.0%) | $6.60 M(+44.4%) |
| June 2001 | - | -$17.92 M(-193.0%) | $4.57 M(-79.5%) |
| Mar 2001 | - | $19.26 M(+769.9%) | $22.27 M(+397.1%) |
| Dec 2000 | $4.48 M(-74.7%) | $2.21 M(+117.8%) | $4.48 M(-75.6%) |
| Sept 2000 | - | $1.02 M(-567.8%) | $18.35 M(-0.5%) |
| June 2000 | - | -$217.30 K(-114.8%) | $18.44 M(-0.9%) |
| Mar 2000 | - | $1.47 M(-90.9%) | $18.61 M(+5.2%) |
| Dec 1999 | $17.69 M(-14.5%) | $16.09 M(+1362.6%) | $17.69 M(+704.0%) |
| Sept 1999 | - | $1.10 M(-2358.7%) | $2.20 M(+633.3%) |
| June 1999 | - | -$48.70 K(-108.9%) | $300.00 K(-98.6%) |
| Mar 1999 | - | $548.70 K(-8.6%) | $21.25 M(+2.7%) |
| Dec 1998 | $20.70 M(+314.0%) | $600.00 K(-175.0%) | $20.70 M(+2.0%) |
| Sept 1998 | - | -$800.00 K(-103.8%) | $20.30 M(-10.6%) |
| June 1998 | - | $20.90 M(>+9900.0%) | $22.70 M(+354.0%) |
| Dec 1997 | $5.00 M(-21.9%) | $200.00 K(-87.5%) | $5.00 M(+4.2%) |
| Sept 1997 | - | $1.60 M(>+9900.0%) | $4.80 M(+50.0%) |
| June 1997 | - | $0.00(-100.0%) | $3.20 M(-58.4%) |
| Mar 1997 | - | $3.20 M(>+9900.0%) | $7.70 M(+20.3%) |
| Dec 1996 | $6.40 M(-31.2%) | $0.00(0.0%) | $6.40 M(0.0%) |
| Sept 1996 | - | $0.00(-100.0%) | $6.40 M(0.0%) |
| June 1996 | - | $4.50 M(+136.8%) | $6.40 M(+236.8%) |
| Mar 1996 | - | $1.90 M(-38.7%) | $1.90 M(-40.6%) |
| Dec 1995 | $9.30 M(+190.6%) | - | - |
| Dec 1994 | $3.20 M(-36.0%) | - | - |
| Mar 1994 | - | $3.10 M(-247.6%) | $3.20 M(-36.0%) |
| Dec 1993 | $5.00 M | -$2.10 M(-200.0%) | $5.00 M(-29.6%) |
| Sept 1993 | - | $2.10 M(+2000.0%) | $7.10 M(+42.0%) |
| June 1993 | - | $100.00 K(-98.0%) | $5.00 M(+2.0%) |
| Mar 1993 | - | $4.90 M | $4.90 M |
FAQ
- What is Synthetic Biologics annual cash flow from financing activities?
- What is the all time high annual CFF for Synthetic Biologics?
- What is Synthetic Biologics annual CFF year-on-year change?
- What is Synthetic Biologics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Synthetic Biologics?
- What is Synthetic Biologics quarterly CFF year-on-year change?
- What is Synthetic Biologics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Synthetic Biologics?
- What is Synthetic Biologics TTM CFF year-on-year change?
What is Synthetic Biologics annual cash flow from financing activities?
The current annual CFF of SYN is $74.00 M
What is the all time high annual CFF for Synthetic Biologics?
Synthetic Biologics all-time high annual cash flow from financing activities is $74.00 M
What is Synthetic Biologics annual CFF year-on-year change?
Over the past year, SYN annual cash flow from financing activities has changed by +$70.64 M (+2103.10%)
What is Synthetic Biologics quarterly cash flow from financing activities?
The current quarterly CFF of SYN is $0.00
What is the all time high quarterly CFF for Synthetic Biologics?
Synthetic Biologics all-time high quarterly cash flow from financing activities is $74.00 M
What is Synthetic Biologics quarterly CFF year-on-year change?
Over the past year, SYN quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Synthetic Biologics TTM cash flow from financing activities?
The current TTM CFF of SYN is -$1.38 M
What is the all time high TTM CFF for Synthetic Biologics?
Synthetic Biologics all-time high TTM cash flow from financing activities is $77.36 M
What is Synthetic Biologics TTM CFF year-on-year change?
Over the past year, SYN TTM cash flow from financing activities has changed by -$78.74 M (-101.78%)